Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - Salarius Pharmaceuticals, Inc. | slrx12312019-322exhibi.htm |
| EX-32.1 - EX-32.1 - Salarius Pharmaceuticals, Inc. | slrx12312019-321exhibi.htm |
| EX-31.2 - EX-31.2 - Salarius Pharmaceuticals, Inc. | slrx12312019-312exhibi.htm |
| EX-31.1 - EX-31.1 - Salarius Pharmaceuticals, Inc. | slrx20191231ex-311.htm |
| EX-23.2 - EX-23.2 - Salarius Pharmaceuticals, Inc. | slrx12312019weavercons.htm |
| EX-10.9 - EX-10.9 - Salarius Pharmaceuticals, Inc. | slrx20191231-brucemccr.htm |
| EX-10.7 - EX-10.7 - Salarius Pharmaceuticals, Inc. | slrx20191231seperation.htm |
| EX-4.9 - EX-4.9 - Salarius Pharmaceuticals, Inc. | slrx12312019descriptio.htm |
| 10-K - 10-K - Salarius Pharmaceuticals, Inc. | flks-20191231.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
a.Registration Statement (Form S-8 No. 333-201816) pertaining to the 2014 Equity Incentive Plan, 2015 Equity Incentive Plan and 2015 Employee Stock Purchase Plan of Salarius Pharmaceuticals, Inc. (formerly known as Flex Pharma, Inc.);
b.Registration Statement (Form S-8 Nos. 333-210283, 333-216534, 333-223499 and 333-230104) pertaining to the 2015 Equity Incentive Plan and 2015 Employee Stock Purchase Plan of Salarius Pharmaceuticals, Inc. (formerly known as Flex Pharma, Inc.);
c.Registration Statement (Form S-3 No. 333-210289 and 333-231010) of Salarius Pharmaceuticals, Inc. (formerly known as Flex Pharma, Inc.);
d.Registration Statement (Form S-1 No. 333-235879) of Salarius Pharmaceuticals, Inc.
of our report dated March 23, 2020, with respect to the consolidated financial statements of Salarius Pharmaceuticals, Inc. included in this Annual Report (Form 10-K) of Salarius Pharmaceuticals, Inc. for the year ended December 31, 2019.
/s/ Ernst & Young LLP
Houston, Texas
March 23, 2020